“…Ribose modifications are not limited to substitutions in structure; nucleic acid analogs with a modified structure of the furanose cycle, such as derivatives containing 6-membered (hexitol [HNA] Fisher et al, 2009, cyclohexenic [CeNA] Nauwelaerts et al, 2007, and altritol [ANA] Fisher et al, 2007 nucleic acids) and 7-membered rings (oxepanic nucleic acid [ONA] Sabatino and Damha, 2007), bicyclic (locked nucleic acids [LNA] Braasch et al, 2003, 2′-deoxymethanocarbanucleosides [MCs] Terrazas et al, 2011), tricyclic (tricyclo-DNA [tc-DNA] Goyenvalle et al, 2015), and acyclic (unlocked nucleic acid [UNA] Jensen et al, 2008; Langkjaer et al, 2009) derivatives, can protect siRNAs from the action of nucleases and in some cases (CeNA, LNA, and UNA) do not inhibit RNAi (Herdewijn and Juliano, 2007; Deleavey and Damha, 2012). Among the 6-membered nucleic acid derivatives, CeNA is most suitable for modifying siRNA, since its complementary interaction with RNA stabilizes the duplex, increasing the melting point by 1.5°C per modified base and increases the oligoribonucleotide resistance to degradation in serum (Wang et al, 2001). Bicyclic derivatives (LNA) can even more significantly increase the melting temperature of siRNA.…”